. In contrast, most of mammals have methylations of cytosine bases in the symmetric CG contexts, which are estimated to occur at ~70-80% of CG dinucleotides throughout the genome (Law and Jacobsen 2010) . The CpG dinucleotides in dense clusters known as CpG islands are mostly observed in the promoter regions and transposons such as long interspersed nucleotide elements (LINE elements) and Alu repetitive elements (He et al. 2014) . Aberrant DNA methylations are involved in the aging process and diseases, including cancer and psychiatric disorders such as schizophrenia (Feinberg 2007; Pun et al. 2011) , and can lead to pleiotropic morphological defects in plants (Law and Jacobsen 2010) . A D r a f t 4 method for rapid measurement of 5-methylcytosine will aid our understanding of the roles of DNA methylation in biology and medicine.
Several techniques are available for determination of methylation of a single cytosine nucleotide on the basis of bisulfite conversion methods, which convert unmethylated cytosine to uracil leaving 5-methylcytosine unaltered. The sequence differences between methylated and unmethylated cytosine after bisulfite conversion can be determined by microarray-or deep sequencing-based methods for genome-wide analysis, or by pyrosequencing, MALDI/TOF/Sequenom, combined bisulfite restriction analysis (COBRA), methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) and methylation-specific PCR (MSP) for locus-specific analysis (Umer and Herceg 2013) . Bisulfite sequencing-based methods give most accurate information about methylation status at individual CpG site in locus-specific or genome-wide regions, however, the requirements for large amounts of DNA, labor-intensive procedures and costly machines limit their use in general laboratories.
PCR-based methods such as COBRA, Ms-SNuPE and MSP are considered practical with merits of very low sample consumption, even though these methods may yield false-positive results or sequence-specific bias due to incomplete enzymatic digestion or PCR artifacts due to over-amplification.
We describe a bisulfite conversion-specific one-label extension (BS-OLE) method for quantification of methylation at individual CpG sites. The method uses template-directed primer extension with incorporation of fluorescence-labeled dCTP D r a f t 5 or dUTP measured by fluorescence polarization (FP) to quantify the levels of methylated and unmethylated cytosine after bisulfite conversion. The principle of FP is based on the observation that, when a small fluorescent molecule is excited by plane polarized light, the emitted light is more highly polarized if the molecule is stationary throughout the excited state (Sun et al. 2014) . In BS-OLE, incorporation of fluorescence-labeled dCTP or dUTP into the extension primer displays relatively little movement during excitation and the emitted light will remain highly polarized. By contrast, the unincorporated fluorescent dCTP or dUTP molecules rotate and tumble rapidly, such that the emitted light is more depolarized relative to the excitation plane.
The FP technique has been used in the analysis of molecular interactions of specific DNA sequences (Murakami et al. 1991; Ju et al. 2009 ) and of methylation status (Wu et al. 2010 ) based on hybridization with fluorescent probes. FP is used in DNA genotyping (Hsu et al. 2001; Akula et al. 2002; Yu et al. 2006; Sun et al. 2014 ) and genome-wide DNA methylation (Zhao and Xue 2012) based on single-nucleotide extension with fluorescent nucleotides. To our knowledge, however, no application of FP to the estimation of DNA methylation at the single base level has been reported.
The FP measurements can be performed with DNA on 96-or 384-well plates without the need for post-extension purification steps and, therefore, BS-OLE is well suited to high-throughput multi-sample applications in biological and medical studies. 
Materials and Methods

Human genomic DNA preparation and bisulfite conversion
Human glioblastoma cell lines of U87, A172, T98G and M059K, as well as human embryonic kidney 293T (HEK293T) cell line, are cultured using standard methods.
The HEK293T cells are treated with 5-aza-2ʹ-deoxycytidine (5-aza-dC; SigmaAldrich, Sweden) for 3 days prior to being harvested. Genomic DNA from cell lines and human peripheral blood cells is extracted with DNAzol ® Reagent (Invitrogen, USA) and is employed for methylation analysis after bisulfite conversion.
Bisulfite conversion of genomic DNA is treated by denaturing 1µg genomic DNA with 0.3M NaOH at 42°C for 20 min, followed by 95°C for 3min and 0°C for 1 min, and incubating at pH 5.0 with sodium metabisulfite (2.0 M) and hydroquinone (0.5 mM) at 55°C for 16h in the dark overlaid with mineral oil (Pun et al. 2011 ).
Converted DNA is purified with Promega Wizard DNA Clean Up Systerm (Promega, USA). The eluted DNA is incubated with NaOH (0.3M) at 37°C for 15 min and neutralized by 3M NH4-acetate to pH 7.0. The neutralized DNA is precipitated by 75% ethanol and recovered in 20 µl of TE buffer. Bisulfite-converted DNA is stored at -20°C until ready for BS-PCR. for 45 min at 37°C followed by 15 min at 85°C.
BS-PCR amplification
Methylated or unmethylated control DNA generation
In order to get control DNAs with unmethylation or 100% methylation at the target CpG dinucleotide (S1 site), 250-bp LINE BS-PCR products from bisulfite-converted human genomic DNA are cloned into the pMD18T vector by standard TA cloning according to manufacture protocol (TaKaRa). Because unmethylated C is replaced by T after BS-PCR amplification, any presence of C on the sequence represents a D r a f t 8 methylated C allele at CpG dinucleotides in the bisulfite-converted DNA. The methylation status (viz. TpG or CpG) at the target S1 site is identified by sequencing recombinant plasmid DNA from a single clone. The clone with a TpG dinucleotide at the S1 site represents the unmethylated DNA, and the clone with a CpG dinucleotide at the S1 site represents 100% methylated DNA (Supplementary Figure 1B) . The plasmids are purified using a Wazard DNA Miniprep Kit (Promega), the amount of DNA is quantified by measuring the optical density (O.D.) at 260nm with Thermo Scientific Nanodrop 2000 Spectrophotometer (ThermoFisher Scientific Inc. USA).
Mixtures of 100% methylated (CpG at the S1 site) and unmethylated (TpG at the S1 site) plasmid DNA in various proportions are employed for methylation analysis with BS-OLE or COBRA.
BS-OLE assay
The BS-OLE assay is performed in two separate reactions to quantify the level of methylated (viz.C) or unmethylated (viz. T) nucleotide, respectively, at the target S1 site as illustrated by 
COBRA assay
Because the methylated form of the target S1 site in the 250 bp LINE PCR product of bisulfite-converted DNA is accordant with Taq I cleavage TCGA site (the underlined CG for the target S1 site, Supplementary Figure 1B) and its unmethylated form (TTGA) cannot be restricted by Taq I, the methylation level of the target S1 site examined by BS-OLE can be validated by COBRA assay with Taq I restriction enzyme (Xiong and Laird 1997) . In COBRA assay, the 250 bp LINE PCR product of Thus, dCTP/(dCTP+dUTP) gives the fraction of the methylated CpG site being examined.
Stabilization and accuracy of BS-OLE
The BS-OLE assay is used to determine the methylation level of the target TCGA site (S1 site) in the LINE1 element with various amounts of PCR products from bisulfite-converted human genomic DNA of peripheral blood cells (Figure 2A ). An estimated 57±1% methylation for this target site is provided by the regression D r a f t analysis (broken line), which has a slight negative slope of -0.0011% ng -1 over the concentration range of 28-450 ng DNA/assay. The BS-OLE assay is further used for various amounts of PCR products from plasmid DNA with 25% methylation at the S1 site, which is a mixture of 100% methylated (CpG at the S1 site) and unmethylated (TpG at the S1 site) plasmid DNA as described in Materials and Methods. The percentage methylation of the S1 site is estimated at 12.5-200 ng DNA/assay by the regression analysis ( Figure 2B , broken line with open circles), which has a slight positive slope of 0.0053% ng -1 , leading to a fairly stable percentage methylation estimate of 33±1% over this range of DNA concentration, slightly higher than the expected level of 25% methylation. Mixtures (100 ng of methylated and unmethylated plasmid DNA at the S1 site in various proportions) are analyzed by BS-OLE ( Figure   2C ). The estimated level of methylation at the S1 site is 26±5%, 40±4%, 53±5%
and 76±2% for the 20%, 40%, 60% and 80% methylated preparations, respectively (R 2 = 0.96 for the linear regression line), demonstrating the applicability of BS-OLE over this range of DNA methylation levels.
Validation of BS-OLE by the COBRA assay
The validity of BS-OLE assay is assessed against COBRA analysis. The TaqI by Gel-Image software yields the total of methylated 250 bp DNA at the S1 site that is digested by TaqI, which corresponds to the percentage methylation in the mixture.
The COBRA method gives estimates of 23±0%, 45±3%, 62%±3% and 78±6%
for the preparations with 20%, 40%, 60% and 80% methylation at the S1 site, respectively ( Figure 2D ). When the BS-OLE estimated percentages are plotted against the COBRA-estimated values, extensive agreement is obtained by linear regression analysis (R 2 = 0.9581, P <0.0001), which provides significant cross-validation of the BS-OLE method by the independent COBRA method.
Analysis of DNA methylation from cancer cell lines
The BS-OLE assay is used to analyze DNA hypomethylation of HEK293T cells induced by 5-aza-dC, a known DNA methylation inhibitor ( Figure 3A) . It is shown that the DNA methylation level at the S1 CpG site of the cellular LINE1 DNA is inhibited to 89% of control by 0.25 µΜ of 5-aza-dC (P = 0.03, one-tailed t-test) and to 80% of the control by 0.5 µΜ of 5-aza-dC (P = 0.04, one-tailed t-test). When the BS-OLE assay is applied to human genomic DNA extracted from five human glioblastoma cell lines and a HEK293T cell line (Figure 3B) , estimated methylation levels ranging from 30% to 50% at the S1 site in LINE1 are 49±2%, 41±3%, 39± 1%, 34±3%, 31±2% and 37±4% for cell lines U87, M059K, A172, U2OS, T98G
and HEK293T, respectively.
D r a f t
Discussion DNA methylation is a key epigenetic mechanism in eukaryotic gene regulation, development and disease. Understanding the role of DNA methylation in development and disease requires knowledge of the status of these modifications in the genome.
DNA methylation usually occurs at the C5 position of cytosine within CG dinucleotides in mammalian genomes. In contrast, in plant genomes, 5-methylcytosine in CNG or CHH triplets is as frequent as in CG dinucleotides, and is recently found in embryonic stem cells in mammals (Lister et al. 2009; Lee et al. 2010 ). The BS-OLE method developed in the present study can determine the methylated C in the CG, CNG or CHH sites whatever occurs in a symmetrical or asymmetrical context, because this method examines the methylated C at a single strand DNA through a single-nucleotide primer extension. BS-OLE ， a robust technique to determine the level of the target cytosine in various contexts, can be widely used to methylation study in plant and mammalian fields when a proper extension primer is employed.
Primer extension-based methods are powerful tools for DNA methylation analysis at the single base level. After PCR amplification of bisulfite converted genomic DNA, the single-nucleotide extension is initiated with a primer through incorporation of radioactively or chemically labeled dCTP or dUTP to determine the methylated or unmethylated cytosine in the target CpG site. In assessing labeled reaction products, the BS-OLE procedure avoids the need for radioactive material or complex protocols D r a f t such as separation and washing to remove unincorporated nucleotide by Ms-SNuPE (Gonzalgo and Liang 2007) , four-step pyrosequencing (Karimi et al. 2006) , or prelabeling of PCR amplicons for FRET measurement (Kaminsky et al. 2005; Feng et al. 2010) . Thus, the entire BS-OLE assay can be performed on a 96-or 384-well microtiter plate and is suitable for high-throughput multi-sample analysis.
In the present study, BS-OLE provides stable and accurate estimates of methylation Unmethylated (T nucleotide at the target TC/TGA S1 site) and 100% methylated (C nucleotide at the target S1 site) plasmid DNAs are mixed to prepare samples with different levels of methylation at the S1 site. Amounts ranging from 12.5 to 200 ng of 25% methylated mixture (B) and 100 ng of each preparation with 0%, 20%, 25%, 40%, 60%, 80% or 100% methylation at the S1 site (C) are assayed by BS-OLE, and analyzed by gel electrophoresis (E). E, Lanes from left to right: TaqI-restricted 250 bp DNA with 0%, 20%, 40%, 60%, 80% or 100% methylation at the S1 site. The 
